scispace - formally typeset
Open AccessJournal ArticleDOI

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

TLDR
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption.
Abstract
A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes. This classification scheme provides a basis for establishing in vitro-in vivo correlations and for estimating the absorption of drugs based on the fundamental dissolution and permeability properties of physiologic importance.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Pharmaceutical quality by design: product and process development, understanding, and control.

TL;DR: Implementation of QbD will enable transformation of the chemistry, manufacturing, and controls (CMC) review of abbreviated new drug applications into a science-based pharmaceutical quality assessment.
Journal ArticleDOI

Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.

TL;DR: Viable formulation options for poorly water-soluble drugs, such as crystal modification, micronization, amorphization, self-emulsification, cyclodextrin complexation, and pH modification are reviewed on the basis of the biopharmaceutics classification system of drug substances.
Journal ArticleDOI

Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs

TL;DR: With the array of compendial and physiological media available, it should be possible to design a suitable set of tests to predict the in vivo dissolution of both class I and II drugs from immediate release formulations.
Journal ArticleDOI

Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

TL;DR: In this article, the authors reviewed several novel examples of pharmaceutical cocrystals from the past decade and analyzed the enhanced solubility profiles of cocrystal profiles, showing that the peak dissolution for pharmaceutical cocystals occurs in a short time (<30 min), and high-solubility is maintained over a sufficiently long period (4-6 h) for the best cases.
Journal ArticleDOI

Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification

TL;DR: The results suggest that a satisfactory bioequivalence (BE) test for more than 55% of the high-solubility Class 1 and Class 3 drug products on the WHO Essential Drug List may be based on an in vitro dissolution test.
References
More filters
Book

Diffusion: Mass Transfer in Fluid Systems

TL;DR: An overview of diffusion and separation processes brings unsurpassed, engaging clarity to this complex topic as mentioned in this paper, which is a key part of the undergraduate chemical engineering curriculum and at the core of understanding chemical purification and reaction engineering.
Journal ArticleDOI

Transit of pharmaceutical dosage forms through the small intestine.

S S Davis, +2 more
- 01 Aug 1986 - 
TL;DR: The gastrointestinal transit of pharmaceutical dosage forms has been measured in 201 studies in normal subjects using gamma scintigraphy and has implications for the design of dosage forms for the sustained release of drugs in specific positions in the gastrointestinal tract.
Journal ArticleDOI

The effect of particle size distribution on dissolution rate and oral absorption

TL;DR: In this article, a computer method has been devised to describe the theoretical dissolution rate of a polydisperse powder under non-sink conditions based on its percent weight particle size distribution.
Journal ArticleDOI

Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds

TL;DR: The correlation between fraction dose absorbed in humans and Pw* determined from steady-state perfused rat intestinal segments gives an excellent correlation, indicating that Pw*, is one of the key variables controlling oral drug absorption and that the correlation may be useful for estimating oral drugabsorption in humans regardless of the mechanism of absorption.
Journal ArticleDOI

Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model.

TL;DR: It is shown that the extent of drug absorption is expected to be highly variable when Dn and Do are approximately one, and a microscopic mass balance approach has been developed to predict the fraction dose absorbed of suspensions of poorly soluble compounds.
Related Papers (5)